Martin; Flavius
Patent Applications and Registrations
Patent applications and USPTO patent grants for Martin; Flavius.The latest application filed is for "combination therapy for b cell disorders".
- Martin; Flavius - Hayward CA
- - Hayward CA US
- Martin; Flavius - Foster City CA
| Patent | Date |
|---|---|
| Methods for treating, diagnosing, and monitoring rheumatoid arthritis Grant 9,822,400 - Dennis, Jr. , et al. November 21, 2 | 2017-11-21 |
| Methods and compositions related to B cell assays Grant 9,726,673 - Martin August 8, 2 | 2017-08-08 |
| Combination Therapy For B Cell Disorders App 20140377257 - CHAN; Andrew ; et al. | 2014-12-25 |
| Methods For Treating, Diagnosing, And Monitoring Rheumatoid Arthritis App 20140341887 - DENNIS, JR.; Glynn ; et al. | 2014-11-20 |
| Methods For Use With Baff Antagonists App 20140213470 - Hsu; Yen-Ming ; et al. | 2014-07-31 |
| Methods for treating, diagnosing, and monitoring rheumatoid arthritis Grant 8,728,730 - Dennis, Jr. , et al. May 20, 2 | 2014-05-20 |
| Methods for use with BAFF antagonists Grant 08617545 - | 2013-12-31 |
| Methods for use with BAFF antagonists Grant 8,617,545 - Hsu , et al. December 31, 2 | 2013-12-31 |
| Methods For Treating, Diagnosing, and Monitoring Rheumatoid Arthritis App 20110052488 - Dennis, JR.; Glynn ; et al. | 2011-03-03 |
| Methods for Use with Baff Antagonists App 20100330066 - Hsu; Yen-Ming ; et al. | 2010-12-30 |
| Polypeptides That Bind Br3 And Uses Thereof App 20100280227 - AMBROSE; CHRISTINE M. ; et al. | 2010-11-04 |
| Anti-ox40l Antibodies And Methods Using Same App 20100272738 - Martin; Flavius | 2010-10-28 |
| Anti-OX40L antibodies and methods using same Grant 7,812,133 - Martin October 12, 2 | 2010-10-12 |
| Combination Therapy For B Cell Disorders App 20100143352 - Chan; Andrew ; et al. | 2010-06-10 |
| Anti-ox40l Antibodies And Methods Using Same App 20090053230 - Martin; Flavius | 2009-02-26 |
| Polypeptides That Bind Br3 and Uses Thereof App 20080181888 - Ambrose; Christine M. ; et al. | 2008-07-31 |
| Transgenic mice expressing human CD20 and/or CD16 Grant 7,402,728 - Chan , et al. July 22, 2 | 2008-07-22 |
| Method for Augmenting B Cell Depletion App 20080075719 - Chan; Andrew C. ; et al. | 2008-03-27 |
| Methods and compositions related to B cell assays App 20070212733 - Martin; Flavius | 2007-09-13 |
| Transgenic mice expressing human cd20 and/or cd16 App 20060218655 - Chan; Andrew Chee-Yuen ; et al. | 2006-09-28 |
| Transgenic mice expressing human cd20 App 20060179501 - Chan; Andrew Chee-Yuen ; et al. | 2006-08-10 |
| Method for augmenting B cell depletion App 20050276803 - Chan, Andrew C. ; et al. | 2005-12-15 |
| Combination therapy for B cell disorders App 20050163775 - Chan, Andrew ; et al. | 2005-07-28 |
| Combination therapy for B cell disorders App 20050095243 - Chan, Andrew ; et al. | 2005-05-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 